iOS app Android app

Susan L. Solomon
GET UPDATES FROM Susan L. Solomon
 
Susan L. Solomon is the Co-founder and Chief Executive Officer of The New York Stem Cell Foundation, which was established in 2005 to provide private support for human embryonic stem cell research. Ms. Solomon has served on the Board of Directors of the Juvenile Diabetes Research Foundation in New York City for more than a decade. As an active health-care advocate she is also a member of NYAMR (New Yorkers for the Advancement of Medical Research) and the New York Council of the Joslin Diabetes Center. An attorney by training, Ms. Solomon practiced law with Debevoise & Plimpton before beginning a twenty-year career in new media, entertainment and investment banking. She was founding Chief Executive Officer of Sothebys.com, and has served as Chairman and Chief Executive Officer of Lancit Media Productions and as President of Sony Worldwide Networks, a pioneering internet broadcasting provider, and has also worked as an executive at MacAndrews & Forbes Holdings and MMG Patricof & Co and was the founding executive of Solomon Partners. She is a member of the Board of Directors and the Executive Committee of Regional Plan Association, and a member of the Board of the New York Festival of Song. She has three sons and is married to Paul Goldberger, the Pulitzer Prize-winning writer on architecture.

Blog Entries by Susan L. Solomon

Stem Cell Research: Science, Not Politics

0 Comments | Posted September 22, 2010 | 11:04 AM

On October 31, 1940, Franklin Delano Roosevelt dedicated the Campus of the National Institutes of Health in Bethesda, Maryland, just a few miles from here. That day, knowing we were moving toward a world war, he said:

The total defense, which this Nation seeks, involves a great deal more than building...

Read Post

Opportunity for Excellence: The Critical Role of State Programs in the New Federal Landscape

0 Comments | Posted June 12, 2009 | 10:17 AM

Speech delivered in Albany, NY on June 12, 2009

Good morning. It is an honor to be speaking to all of you today. I'd like to start by thanking Dr. Richard Daines, the New York State Commissioner of Health, for his leadership as head of the Funding and Ethics Committees...

Read Post

Patients Before Politics: Putting Science First

0 Comments | Posted March 9, 2009 | 11:37 AM

For the last eight years, human embryonic stem cell research -- which is improving our understanding of how we can treat and defeat diseases such as Parkinson's and diabetes -- has been a hostage of presidential politics. Monday's executive order by President Barack Obama changes that, lifting many restrictions on...

Read Post

The Stem Cell Wars Are Not Over

0 Comments | Posted November 30, 2007 | 10:08 AM

By Susan L. Solomon and Zach W. Hall

Nothing would give the millions of people afflicted with heart disease, diabetes, cancer, Parkinson's disease, Alzheimer's disease and spinal cord injuries a greater thrill than to be able to rejoice that the debates around stem cell research are finally over, and "the...

Read Post

After Bush's Veto, What is Next for Stem Cell Research?

0 Comments | Posted June 20, 2007 | 11:04 AM

For the second consecutive year, President Bush is vetoing legislation that would expand the range of human embryonic stem cell research eligible for federal funding. The Stem Cell Research Enhancement Act did not represent a sea change in federal policy, but would have been an important step toward making...

Read Post

Today's Stem Cell Bill: A Politically Expedient Approach

0 Comments | Posted July 18, 2006 | 7:44 PM

H.R 810 represents a step in the right direction, but it is ultimately a politically expedient approach to tackling this critical issue. It does not address the fact that the federal government should be funding the most important form of embryonic stem cell research, Somatic Cell Nuclear Transfer (SCNT), which...

Read Post